No attachments available.
NonSurgical Debridement
Contact and place of performance
Jonathan Gonzalez, Contracting Officer
Washington, DC 20024
USA
This acquisition will allow BARDA to support procurement of an FDA-approved enzymatic debridement product and support development of a next generation product for increased preparedness value.
The Administration for Strategic Preparedness and Response issued this award notice for solicitation number 75A50126C00002 to support the Biomedical Advanced Research and Development Authority in the procurement of an FDA-approved enzymatic debridement product. The acquisition also funds the development of a next-generation product designed to increase preparedness value. This requirement is classified under NAICS code 541714 for Research and Development in Biotechnology (except Nanobiotechnology) and PSC 6510 for Surgical Dressing Materials.
The primary place of performance for this contract is Washington, DC. There is no set-aside assigned to this action, listed as acronym NONE and explanation NONE. Published on April 2, 2026, the notice identifies Jonathan Gonzalez as the contracting officer and includes zero attachments.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.